Trials / Sponsors / SynDevRx, Inc.
SynDevRx, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | 2022-08-26 |
| Completed | A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors Advanced Malignancy, Advanced Solid Tumors, Neoplasm | Phase 1 | 2016-02-01 |